Trio Pharmaceuticals

Developer of antibody drugs for treating cancer

placeSan Francisco, California, United States calendar_todayFounded 2018 groups7 employees language triopharmaceuticals.com

Registered entities

Social engagement

Social engagement: 1.1K social following, 6 posts in the last 12 months — below the industry typical range.

Investor mix

11 investors on record; lead investors include Friedman Bioventure.

Investor typeCountShare
Venture capital655%
Angel & family office327%
Accelerator & incubator19%
Other / undisclosed19%

Recent activity

18 Nov 2025
Recognition
8 Oct 2025
Leadership hire
Chairman of the Board of Directors
6 Oct 2025
Product launch
TRAILBodyTM
Coming soon